SCHEMBL17345596

SCHEMBL17345596

COC/C=C/c1ccc(C=O)c(C)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IRAK4 Q9NWZ3 1/20 0.37
▸ ALDH1A1 P00352 5/20 0.36
▸ TSHR P16473 2/20 0.36
▸ NPC1 O15118 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ TUBB1 Q9H4B7 6/20 0.34
▸ GLO1 Q04760 1/20 0.34
▸ MAOA P21397 1/20 0.33
▸ TRIM24 O15164 1/20 0.33
▸ TYR P14679 1/20 0.33
▸ TRIM33 Q9UPN9 1/20 0.33
▸ CHRM2 P08172 1/20 0.33
▸ CHRM1 P11229 1/20 0.33
▸ CHRM3 P20309 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ LMNA P02545 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28721892 0.79 ALDH1A1 (0.46) ALDH1A1TSHRTUBB1GLO1LMNA
SCHEMBL17345595 0.79 NPC1 (0.39) ALDH1A1TSHRNPC1PKMRAB9A
SCHEMBL15989275 0.78 MAPT (0.47) ALDH1A1TUBB1LMNAMAPTHTT
SCHEMBL4450324 0.78 IRAK4 (0.41) IRAK4ALDH1A1MAOAMAPT
SCHEMBL28707673 0.78 IRAK4 (0.41) IRAK4ALDH1A1MAOAMAPT
SCHEMBL6610732 0.77 ALDH1A1 (0.48) ALDH1A1TSHRTYRLMNAMAPT
SCHEMBL8718534 0.77 ALDH1A1 (0.48) ALDH1A1TSHRTYRLMNAMAPT
SCHEMBL29268893 0.76 IRAK4 (0.40) IRAK4ALDH1A1MAOAMAPT
SCHEMBL17345594 0.75 ALDH1A1 (0.43) ALDH1A1TSHRNPC1PKMRAB9A
SCHEMBL823127 0.74 ALDH1A1 (0.50) ALDH1A1TSHRNPC1PKMRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9663475-B2 2 amino-3,4-dihydrcquinazoline derivatives and the use thereof as cathepsin D inhibitors MERCK PATENT GMBH (DE) 2017-05-30 — — US disclosed
US-20150361053-A1 2 AMINO-3,4-DIHYDRCQUINAZOLINE DERIVATIVES AND THE USE THEREOF AS CATHEPSIN D INHIBITORS MERCK PATENT GMBH (DE) 2015-12-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150361053-A1 2 AMINO-3,4-DIHYDRCQUINAZOLINE DERIVATIVES AND THE USE THEREOF AS CATHEPSIN D INHIBITORS CTSD, CTSZ, CTSK IRAK4 1269/4885ALDH1A1 973/4885TSHR 4711/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback